ClinicalTrials.Veeva

Menu

Efficacy of Osteopathic Treatment on the Side Effects of Curative Treatments of Lymphoblastic Leukemia in Pediatrics (Leucosteo)

A

Assistance Publique - Hôpitaux de Paris

Status

Not yet enrolling

Conditions

Lymphoblastic Leukemia

Treatments

Other: osteopathy

Study type

Observational

Funder types

Other

Identifiers

NCT05664230
APHP220699
IDRCB: 2022-A01261-42 (Registry Identifier)

Details and patient eligibility

About

During the curative treatment of cancer, pain often remains the dominant symptom affecting the physical and psychological state of the patient.

Osteopathy is an exclusively manual practice whose goal is to compensate for mobility dysfunctions of the tissues of the human body. It can be used as a complementary treatment for cancer pain when pain medications are not enough.

The aim of this study is to examine the effectiveness of osteopathy in reducing pain intensity and improving quality of life in patients treated for pediatric acute lymphoblastic leukemia.

Full description

During the curative treatment of cancer, pain often remains the dominant symptom affecting the physical and psychological state of the patient.

Osteopathy is an exclusively manual practice whose goal is to compensate for mobility dysfunctions of the tissues of the human body. It can be used as a complementary treatment for cancer pain when pain medications are not enough.

The aim of this study is to examine the effectiveness of osteopathy in reducing pain intensity and improving quality of life in patients treated for pediatric acute lymphoblastic leukemia.

Primary objective :

To evaluate the effectiveness of five osteopathy sessions at regular intervals on the characteristics of the pain felt in patients aged 1 to 10 years treated for acute lymphoblastic leukemia using the HEDEN scale (Hetero-Evaluation Pain Child).

Enrollment

15 estimated patients

Sex

All

Ages

1 to 10 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient managed and treated with a diagnosis of acute lymphoblastic leukemia
  • Patient between 1 and 10 years of age
  • Patient with pain at inclusion, or pain at diagnosis related to leukemia
  • Social security affiliation or entitlement
  • Signature of informed consent by both parents

Exclusion criteria

  • No pain reported at the time of management or diagnosis
  • Surgery less than 30 days old
  • Patient with another contraindication to osteopathic treatment (worsening of the condition, bleeding syndrome), or a psychiatric pathology that prevents the scales from being used.

Trial contacts and locations

1

Loading...

Central trial contact

Laurent STUBBE, MD; Benoit BRETHON, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems